Table 2.
Characteristic | Medical and radiation oncologists (n = 721) |
Surgeons (n = 794) |
||||
Adjusted OR† (95% CI) | Adjusted percentage‡ (95% CI) | P§ | Adjusted OR† (95% CI) | Adjusted percentage‡ (95% CI) | P§ | |
Physicians | ||||||
Specialty | ||||||
Medical oncology | 5.2 (2.8 to 9.4) | 87.9 (84.9 to 91.0) | <.001 | — | — | .010 |
Radiation oncology | 1.00 (referent) | 66.2 (59.1 to 73.3) | — | — | ||
General surgery | — | — | 1.00 (referent) | 31.9 (27.8 to 36.0) | ||
Colorectal surgery | — | — | 1.0 (0.5 to 2.0) | 31.3 (19.6 to 43.1) | ||
Thoracic surgery | — | — | 1.3 (0.7 to 2.2) | 35.9 (27.2 to 44.6) | ||
Surgical oncology | — | — | 3.9 (1.8 to 8.6) | 58.3 (43.2 to 73.3) | ||
Other surgical subspecialty | — | — | 2.1 (0.8 to 5.5) | 46.0 (27.8 to 64.2) | ||
Age, y | ||||||
<50 | 1.7 (1.0 to 3.1) | 82.7 (78.7 to 86.7) | .203 | 1.2 (0.7 to 1.9) | 36.6 (31.8 to 41.4) | .413 |
50–59 | 1.5 (0.8 to 2.8) | 81.4 (76.8 to 86.1) | 0.9 (0.5 to 1.5) | 31.9 (26.7 to 37.2) | ||
≥60 | 1.00 (referent) | 76.0 (69.4 to 82.6) | 1.00 (referent) | 33.9 (27.0 to 40.7) | ||
Sex | ||||||
Male | 1.00 (referent) | 79.6 (76.2 to 82.9) | .068 | 1.00 (referent) | 34.3 (30.8 to 37.8) | .726 |
Female | 1.8 (1.0 to 3.3) | 86.0 (80.6 to 91.3) | 1.1 (0.6 to 2.1) | 36.2 (26.0 to 46.4) | ||
US or Canadian medical school graduate | ||||||
Yes | 1.00 (referent) | 79.9 (76.7 to 83.2) | .136 | 1.00 (referent) | 34.0 (30.5 to 37.5) | .355 |
No | 1.6 (0.9 to 3.0) | 85.1 (79.6 to 90.7) | 1.3 (0.7 to 2.4) | 38.9 (28.7 to 49.1) | ||
Practice setting | ||||||
Income increases as a result of enrolling patients on clinical trials | ||||||
Yes | 1.9 (0.7 to 5.1) | 87.0 (78.3 to 95.6) | .214 | 0.9 (0.3 to 2.9) | 33.5 (14.6 to 52.5) | .919 |
No | 1.00 (referent) | 80.3 (77.3 to 83.4) | 1.00 (referent) | 34.5 (31.2 to 37.9) | ||
Practice type | ||||||
Office based, solo | 0.3 (0.1 to 0.6) | 65.5 (53.8 to 77.2) | .018 | 0.8 (0.4 to 1.6) | 32.5 (23.2 to 41.8) | .673 |
Office based, group‖ | 0.8 (0.4 to 1.4) | 81.0 (76.4 to 85.6) | 0.8 (0.5 to 1.3) | 32.9 (27.0 to 38.7) | ||
Hospital based | 1.00 (referent) | 83.8 (79.6 to 88.0) | 1.00 (referent) | 36.0 (31.2 to 40.8) | ||
Practice size, No. of physicians | ||||||
1–5 | 1.00 (referent) | 78.4 (74.3 to 82.5) | .290 | 1.00 (referent) | 32.2 (27.6 to 36.9) | .251 |
6–10 | 1.6 (0.8 to 3.1) | 84.0 (77.7 to 90.4) | 1.1 (0.6 to 1.8) | 33.0 (25.7 to 40.4) | ||
11–20 | 1.7 (0.6 to 4.4) | 84.5 (75.3 to 93.6) | 1.8 (0.9 to 3.5) | 42.6 (31.4 to 53.8) | ||
>20 | 2.4 (0.8 to 7.3) | 88.0 (79.3 to 96.7) | 1.5 (0.9 to 2.4) | 38.8 (31.1 to 46.4) | ||
Study site | ||||||
Five large HMOs¶ | 1.00 (referent) | 83.0 (73.9 to 92.0) | .129 | 1.00 (referent) | 46.9 (34.4 to 59.3) | .004 |
Northern California counties | 1.0 (0.4 to 2.6) | 82.6 (76.9 to 88.4) | 0.5 (0.3 to 1.0) | 34.3 (28.1 to 40.5) | ||
Los Angeles County | 0.8 (0.3 to 2.1) | 80.2 (74.4 to 85.9) | 0.4 (0.2 to 0.9) | 30.9 (24.4 to 37.3) | ||
State of Alabama | 1.1 (0.4 to 3.4) | 84.2 (77.4 to 91.1) | 0.3 (0.1 to 0.7) | 25.0 (17.7 to 32.2) | ||
State of Iowa | 1.0 (0.3 to 3.1) | 83.0 (74.8 to 91.1) | 1.0 (0.4 to 2.6) | 46.6 (32.2 to 61.1) | ||
State of North Carolina | 1.0 (0.3 to 3.2) | 83.2 (74.5 to 91.8) | 0.9 (0.4 to 2.1) | 45.6 (36.4 to 54.9) | ||
Veteran’s Administration | 0.3 (0.1 to 0.8) | 65.9 (55.0 to 76.9) | 0.4 (0.1 to 1.0) | 29.0 (18.2 to 39.9) | ||
Practice affiliated with a CCOP | ||||||
Yes | 2.1 (1.2 to 3.7) | 86.1 (81.7 to 90.5) | .016 | 1.4 (1.0 to 2.0) | 38.3 (32.6 to 44.0) | .094 |
No | 1.00 (referent) | 77.8 (73.9 to 81.7) | 1.00 (referent) | 32.6 (28.6 to 36.6) | ||
Practice affiliated with an NCI-designated cancer center | ||||||
Yes | 2.8 (1.2 to 6.4) | 89.7 (83.5 to 95.8) | .023 | 1.7 (1.1 to 2.6) | 41.4 (34.9 to 47.9) | .010 |
No | 1.00 (referent) | 79.2 (75.9 to 82.5) | 1.00 (referent) | 31.6 (27.7 to 35.5) | ||
Physician practice style | ||||||
Percentage of patients in managed care, quartiles | ||||||
0–20 | 0.9 (0.4 to 1.9) | 79.6 (73.8 to 85.4) | .759 | 1.7 (0.9 to 2.9) | 37.5 (30.1 to 44.8) | .190 |
21–49 | 1.3 (0.5 to 3.3) | 83.8 (77.6 to 90.0) | 1.8 (1.0 to 3.4) | 39.4 (31.6 to 47.1) | ||
50–78 | 0.9 (0.4 to 2.0) | 79.9 (73.8 to 86.1) | 1.5 (0.9 to 2.5) | 36.1 (30.0 to 42.3) | ||
79–100 | 1.00 (referent) | 80.8 (74.0 to 87.7) | 1.00 (referent) | 29.1 (23.4 to 34.8) | ||
Teaches medical students and/or residents | ||||||
Yes | 2.7 (1.5 to 5.0) | 87.4 (83.2 to 91.7) | .003 | 1.6 (1.1 to 2.4) | 38.4 (33.7 to 43.1) | .019 |
No | 1.00 (referent) | 75.8 (71.2 to 80.4) | 1.00 (referent) | 30.1 (25.2 to 35.0) | ||
Attends tumor board meetings | ||||||
Weekly | 1.1 (0.5 to 2.5) | 82.7 (79.3 to 86.2) | .076 | 2.9 (1.8 to 4.6) | 42.3 (36.3 to 48.3) | <.001 |
Monthly | 0.6 (0.2 to 1.3) | 74.3 (67.6 to 81.1) | 2.1 (1.3 to 3.5) | 36.6 (30.8 to 42.3) | ||
Quarterly or less frequently | 1.00 (referent) | 81.7 (72.9 to 90.5) | 1.00 (referent) | 23.9 (18.3 to 29.5) | ||
No. of colorectal or lung cancer patients seen per month | ||||||
<5 | 1.00 (referent) | 75.2 (66.5 to 83.9) | .400 | 1.00 (referent) | 28.7 (24.7 to 32.8) | <.001 |
5–9 | 1.8 (0.9 to 3.8) | 82.6 (76.8 to 88.3) | 2.0 (1.3 to 3.3) | 41.8 (33.5 to 50.1) | ||
10–19 | 1.9 (0.8 to 4.3) | 82.9 (77.3 to 88.5) | 2.1 (1.2 to 3.7) | 42.6 (32.7 to 52.5) | ||
≥20 | 1.5 (0.7 to 3.2) | 80.4 (75.9 to 84.9) | 5.1 (2.3 to 11.3) | 60.1 (45.2 to 75.1) | ||
Time spent with a newly diagnosed cancer patient, min | ||||||
<60 | 1.00 (referent) | 81.5 (76.2 to 86.8) | .792 | 1.00 (referent) | 34.9 (31.2 to 38.7) | .584 |
≥60 | 0.9 (0.5 to 1.6) | 80.6 (77.1 to 84.1) | 0.87 (0.5 to 1.4) | 32.7 (25.5 to 39.8) |
— = not applicable; CCOP = Community Clinical Oncology Program; CI = confidence interval; HMO = health maintenance organization; NCI = National Cancer Institute; OR = odds ratio.
Adjusted using multiple logistic regression for all other characteristics in table.
Adjusted using predictive margins for all other characteristics in table.
Based on an overall Wald χ2 test for association obtained from the logistic regression models (two-sided).
Includes office-based HMOs, community health centers, and other (a questionnaire item)
Group Health Cooperative of Puget Sound, Harvard Pilgrim Health Care, Henry Ford Health System, Kaiser Permanente Northwest, and Kaiser Permanente Hawaii.